Mitsubishi UFJ Asset Management Portfolio holdings
AUM
$125B
1-Year Return
23.89%
This Quarter Return
+9.46%
1 Year Return
+23.89%
3 Year Return
+93.04%
5 Year Return
+163.06%
10 Year Return
+400.91%
AUM
$36.7B
AUM Growth
+$5.6B
(+18%)
Cap. Flow
+$3.43B
Cap. Flow
% of AUM
9.36%
Top 10 Holdings %
Top 10 Hldgs %
25.01%
Holding
1,178
New
48
Increased
837
Reduced
168
Closed
53
Top Buys
| 1 |
Microsoft
MSFT
|
+$236M |
| 2 |
Apple
AAPL
|
+$155M |
| 3 |
PayPal
PYPL
|
+$90.8M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$82.5M |
| 5 |
Amazon
AMZN
|
+$78.9M |
Top Sells
| 1 |
Amphenol
APH
|
+$45.8M |
| 2 |
Fidelity National Information Services
FIS
|
+$37.8M |
| 3 |
DRE
Duke Realty Corp.
DRE
|
+$20.6M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$18.1M |
| 5 |
CTXS
Citrix Systems Inc
CTXS
|
+$8.6M |
Sector Composition
| 1 | Technology | 24.28% |
| 2 | Healthcare | 19.27% |
| 3 | Financials | 13.41% |
| 4 | Consumer Staples | 8.81% |
| 5 | Industrials | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1001
4D Molecular Therapeutics
FDMT
$326M
| $248K | ﹤0.01% |
+12,036
| New | +$248K |
|
1002
Codexis
CDXS
$221M
| $245K | ﹤0.01% |
52,389
+28,704
| +121% | +$134K |
|
1003
Iovance Biotherapeutics
IOVA
$858M
| $244K | ﹤0.01% |
40,015
+23,090
| +136% | +$141K |
|
1004
Merus
MRUS
$5.18B
| $240K | ﹤0.01% |
15,372
-159
| -1% | -$2.48K |
|
1005
Maravai LifeSciences
MRVI
$385M
| $238K | ﹤0.01% |
17,370
+9,765
| +128% | +$134K |
|
1006
Xencor
XNCR
$593M
| $236K | ﹤0.01% |
9,107
-1,870
| -17% | -$48.5K |
|
1007
Vir Biotechnology
VIR
$728M
| $232K | ﹤0.01% |
9,302
-641
| -6% | -$16K |
|
1008
Immersion
IMMR
$225M
| $232K | ﹤0.01% |
30,615
-13,076
| -30% | -$99K |
|
1009
BioNTech
BNTX
$24.5B
| $225K | ﹤0.01% |
1,511
+25
| +2% | +$3.72K |
|
|
ONL
1010
Orion Office REIT
ONL
$169M
| $224K | ﹤0.01% |
26,819
| – | – |
|
1011
Novo Nordisk
NVO
$241B
| $222K | ﹤0.01% |
3,244
-300
| -8% | -$20.5K |
|
1012
Sangamo Therapeutics
SGMO
$157M
| $219K | ﹤0.01% |
69,610
+7,906
| +13% | +$24.8K |
|
|
OLP
1013
One Liberty Properties
OLP
$497M
| $217K | ﹤0.01% |
9,618
+2,724
| +40% | +$61.5K |
|
1014
dLocal
DLO
$4.01B
| $211K | ﹤0.01% |
13,706
+7,346
| +116% | +$113K |
|
1015
Vontier
VNT
$6.25B
| $207K | ﹤0.01% |
10,560
| – | – |
|
1016
Atara Biotherapeutics
ATRA
$83.9M
| $203K | ﹤0.01% |
2,480
+522
| +27% | +$42.8K |
|
1017
Sanofi
SNY
$116B
| $203K | ﹤0.01% |
4,133
+893
| +28% | +$43.8K |
|
1018
Novartis
NVS
$248B
| $201K | ﹤0.01% |
2,180
+97
| +5% | +$8.94K |
|
1019
CureVac
CVAC
$1.21B
| $197K | ﹤0.01% |
30,801
+18,689
| +154% | +$119K |
|
|
WSR
1020
Whitestone REIT
WSR
$654M
| $196K | ﹤0.01% |
20,240
| – | – |
|
1021
Ocugen
OCGN
$322M
| $195K | ﹤0.01% |
156,111
+43,484
| +39% | +$54.4K |
|
1022
Editas Medicine
EDIT
$248M
| $194K | ﹤0.01% |
22,953
-74
| -0.3% | -$625 |
|
1023
Azenta
AZTA
$1.35B
| $188K | ﹤0.01% |
3,195
+562
| +21% | +$33.1K |
|
1024
Workiva
WK
$4.32B
| $186K | ﹤0.01% |
2,259
-348
| -13% | -$28.7K |
|
|
NXDT
1025
NexPoint Diversified Real Estate Trust
NXDT
$176M
| $186K | ﹤0.01% |
+16,700
| New | +$186K |
|